Loading…
← CockpitCompetitor Analysis › 3600.HK Modern Dental Group LimitedOpen in the cockpit ↗

Modern Dental Group Limited3600.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Health Care›Medical Specialties
Momentum strong 77
Mkt cap
$844M
US dollars, full cap
Free float
15%
of shares outstanding
$/day
$196,420
20-day average traded
Fwd P/E
8.5×
forward earnings
ROIC−WACC
+13.4 pp
WACC 8.5%
Hurdle
-18 pp
Req g minus delivered
Next earnings
132 days
30 Mar 2027
Close · HKDHK$7.08
1D-1.1%
1W-1.7%
1M-5.0%
3M-14.0%
6M+23.7%
YTD+32.7%
1Y+32.7%
ATR %3.3%
52w lowhigh17.2% off high

What Modern Dental does

Employees: 8,538

Modern Dental at a glance

Size Modern Dental (3600.HK) is a Hong Kong Health Care company (Medical Specialties) with a market value of $844M, the 622nd largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$7.08 on 18 Nov 2026.

Performance Over six months the shares gained 23.7%, against -15.1% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — 4th highest of 21 in its peer set.

Growth Revenue grew 12.5% over the last twelve months (peer median +7.3%); the operating margin is 22.2% (peer median 9.4%).

Valuation It trades at 8.5× forward earnings against a peer median of 26.0× (2nd cheapest of 15).

Price implies For today's price to make sense, revenue must grow about -7% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is -18 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 13.4 points above its cost of capital (8.5% WACC).

Next results Next results expected around 30 Mar 2027 (exchange calendar; dates can move).

Relative performance

10012014021 May 202621 Aug 202618 Nov 20263600.HK 123Peer median 85
Six months, rebased to 100: Modern Dental against the median of its 20 peers (local-currency closes).

Modern Dental financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueHK$3.93BHK$3.74BHK$3.36BHK$3.17BHK$2.83B
Revenue growth—+11%+6%+12%—
Gross profitHK$2.26BHK$2.08BHK$1.80BHK$1.70BHK$1.38B
EBITDAHK$1.02BHK$899MHK$720MHK$684MHK$454M
Net incomeHK$686MHK$597MHK$408MHK$404MHK$220M
Free cash flown/aHK$666MHK$326MHK$377MHK$53.4M
Capital expendituren/aHK$72.0MHK$154MHK$160MHK$185M
Total debtn/aHK$654MHK$924MHK$852MHK$788M

Quarterly statements and history in the cockpit →

Modern Dental competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%-20%-10%0%6033671187301602688656KIDS002658688805688277688068688626688767MCAPAMS688575096530301580BVSAORTSETL3600.HK6-month return →1-month return →
Up and to the right = strong over both horizons. Modern Dental is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%0×200×400×6033671187688656002658688626688767MCAPAMS688575096530BVSAORTKURN3600.HKRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Modern Dental is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%6033671187301602688656002658688805MCAPAMS688575096530301580BVS3600.HKGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Modern Dental is the large dot.

Modern Dental competitors and peer comparison

How Modern Dental compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Modern Dental against its 20 peers (data as of 18 Nov 2026)
Measure3600.HKPeer medianRank in peer set
1-month return-5.0%-8.0%9th highest of 21
6-month return+23.7%-15.1%4th highest of 21
Distance from 52-week high-17.2%-41.9%4th highest of 21
Revenue growth (TTM)+12.5%+7.3%10th highest of 21
Operating margin22.2%9.4%2nd highest of 21
Forward P/E8.5×26.0×2nd cheapest of 15
Growth the price implies (Req g, 7 yrs)-7.1%9.3%2nd least demanding of 13
Growth delivered (Del g)+11.3%+12.2%6th lowest of 13
Hurdle (Req g minus delivered)-18.4 pp-2.7 ppleast demanding of 13
ROIC minus cost of capital+13.4 pp+1.5 pp2nd highest of 21
EV / EBITDA6.3×15.9×2nd cheapest of 8
Net debt / EBITDA-0.2×0.9×2nd least indebted of 9

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Modern Dental 3600.HKHong Kong$844M+24%+12%22%8.5×-7.1%+11.3%
Cisen Pharmaceutical 603367.SSChina$843M-15%-6%8%7.9×-14.6%-1.3%
Cofoe Medical Technology 1187.HKHong Kong$836M-11%+40%10%13.1×-6.4%+6.6%
Shantou Institute of Ultrasonic Instruments 301602.SZChina$858M-25%+4%30%n/a11.1%+4.6%
HOB Biotech 688656.SSChina$858M-33%+6%7%166.9×37.6%+12.4%
OrthoPediatrics KIDSUnited States$826M+71%+16%-8%n/an/an/a
Beijing SDL Technology 002658.SZChina$864M-34%-13%9%22.4×16.8%+2.9%
Ningbo Jansen Superconducting Technologies 688805.SSChina$818M-36%+36%16%n/a35.6%+17.1%
Tinavi Medical Technologies 688277.SSChina$872M-36%-2%-59%n/an/an/a
Beijing Hotgen Biotech 688068.SSChina$815M-37%+8%-94%n/an/an/a
Xiangyu Medical 688626.SSChina$877M-38%0%4%56.2×n/an/a
Hangzhou Biotest Biotech 688767.SSChina$878M-12%-4%3%37.0×n/an/a
MedCap MCAP.STSweden$811M-4%+17%15%25.8×2.7%+20.9%
Advanced Medical Solutions AMS.LUnited Kingdom$811M+27%+6%12%20.7×20.0%+21.4%
Shenzhen YHLO Biotech 688575.SSChina$882M-16%+3%12%30.7×2.0%+12.7%
Seegene 096530.KSSouth Korea$808M-26%+13%13%20.0×-6.7%-15.9%
Aidite (Qinhuangdao) Technology 301580.SZChina$888M-12%+17%18%26.2×19.3%+23.3%
Bioventus BVSUnited States$895M-3%+4%10%13.0×7.5%+12.1%
Artivion AORTUnited States$905M-18%+14%5%383.6×n/an/a
Kuros Biosciences KURN.SWSwitzerland$907M-12%+41%6%70.5×n/an/a
Standard Engineering Technology SETL.NSIndia$783M+168%+45%14%n/an/an/a

Questions

Which companies are Modern Dental's closest peers?
The cockpit's peer set: Cisen Pharmaceutical (603367.SS), Cofoe Medical Technology (1187.HK), Shantou Institute of Ultrasonic Instruments (301602.SZ), HOB Biotech (688656.SS), OrthoPediatrics (KIDS), Beijing SDL Technology (002658.SZ), Ningbo Jansen Superconducting Technologies (688805.SS), Tinavi Medical Technologies (688277.SS).
Is Modern Dental expensive compared with its peers?
On forward p/e it trades at 8.5× against a peer median of 26.0×, 2nd cheapest of 15 in its peer set. For today's price to make sense, revenue must grow about -7% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is -18 pp: the price already allows for a slowdown.
How has Modern Dental stock performed?
Over six months to 18 Nov 2026 the shares returned +23.7% against -15.1% for the median peer; over one year +32.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.